Robert W Herbst

Title: Innovations by Robert W. Herbst in Antibody Drug Conjugation

Introduction

Robert W. Herbst is a notable inventor based in Braintree, MA (US), recognized for his contributions to the field of antibody drug conjugation. With a total of 2 patents, Herbst has made significant advancements that enhance the efficiency and consistency of therapeutic compositions.

Latest Patents

Herbst's latest patents include innovative methods for antibody drug conjugation, purification, and formulation. The first patent outlines methods of producing, purifying, and formulating antibody drug conjugates (ADCs). These methods utilize continuous conjugation processes, single-pass tangential flow filtration, countercurrent diafiltration, and in-line process automation technologies. By implementing these techniques, the methods aim to decrease process times and costs while improving product consistency. The second patent focuses on formulating antibody drug conjugate compositions. This invention provides improved methods that reduce potency variability between batches of ADC and allow for administration within a narrow intended range.

Career Highlights

Robert W. Herbst is currently employed at Immunogen, Inc., where he applies his expertise in the development of antibody drug conjugates. His work has been instrumental in advancing the capabilities of therapeutic compositions in the pharmaceutical industry.

Collaborations

Herbst collaborates with talented professionals such as Gillian Payne and Juma Bridgewater, contributing to a dynamic and innovative work environment.

Conclusion

Robert W. Herbst's contributions to the field of antibody drug conjugation exemplify the impact of innovation in healthcare. His patents not only enhance the efficiency of drug formulation but also ensure consistency in therapeutic applications.